These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11744810)

  • 1. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins.
    Chen S; Evans T; Deng D; Cukiernik M; Chakrabarti S
    Nephron; 2002 Jan; 90(1):86-94. PubMed ID: 11744810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats.
    Evans T; Deng DX; Chen S; Chakrabarti S
    Diabetes; 2000 Apr; 49(4):662-6. PubMed ID: 10871206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats.
    Evans T; Xi Deng D; Mukherjee K; Downey D; Chakrabarti S
    Diabetes Res Clin Pract; 2000 May; 48(2):75-85. PubMed ID: 10802144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.
    Hocher B; Schwarz A; Reinbacher D; Jacobi J; Lun A; Priem F; Bauer C; Neumayer HH; Raschack M
    Nephron; 2001 Feb; 87(2):161-9. PubMed ID: 11244312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.
    Hargrove GM; Dufresne J; Whiteside C; Muruve DA; Wong NC
    Kidney Int; 2000 Oct; 58(4):1534-45. PubMed ID: 11012888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.
    Xu B; Chiu J; Feng B; Chen S; Chakrabarti S
    Diabetes Metab Res Rev; 2008; 24(5):404-12. PubMed ID: 18351623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation.
    Herrero I; Torras J; Riera M; Condom E; Coll O; Cruzado JM; Hueso M; Bover J; Lloberas N; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Apr; 14(4):872-80. PubMed ID: 10328462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.
    Chen S; Evans T; Mukherjee K; Karmazyn M; Chakrabarti S
    J Mol Cell Cardiol; 2000 Sep; 32(9):1621-9. PubMed ID: 10966825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats.
    Roy S; Lorenzi M
    Diabetologia; 1996 Jun; 39(6):735-8. PubMed ID: 8781771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroprotective effect of bosentan in diabetic rats.
    Cosenzi A; Bernobich E; Trevisan R; Milutinovic N; Borri A; Bellini G
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):752-6. PubMed ID: 14639097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-induced vascular dysfunction in the retina: role of endothelins.
    Deng D; Evans T; Mukherjee K; Downey D; Chakrabarti S
    Diabetologia; 1999 Oct; 42(10):1228-34. PubMed ID: 10525664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.
    Ceol M; Nerlich A; Baggio B; Anglani F; Sauer U; Schleicher E; Gambaro G
    Lab Invest; 1996 Feb; 74(2):484-95. PubMed ID: 8780166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of endothelin A receptor sites in the rabbit diabetic kidney: potential relevance to the early pathogenesis of diabetic nephropathy.
    Khan MA; Dashwood MR; Mumtaz FH; Thompson CS; Mikhailidis DP; Morgan RJ
    Nephron; 1999; 83(3):261-7. PubMed ID: 10529633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
    Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H
    Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-mediated remodeling in aortas of diabetic rats.
    Fukuda G; Khan ZA; Barbin YP; Farhangkhoee H; Tilton RG; Chakrabarti S
    Diabetes Metab Res Rev; 2005; 21(4):367-75. PubMed ID: 15580650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
    Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
    Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.